The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Self-citationPetrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
de Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J.-P., Kocak, I., Gravis, G., Bodrogi, I., Mackenzie, M. J., Shen, L., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61389-x · Cited by 3,318
Epstein, J. I., Allsbrook, W. C., Amin, M. B., & Egevad, L. L. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000173646.99337.b1 · Cited by 2,763
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Thompson, I. M., Tangen, C. M., Paradelo, J., Lucia, M. S., Miller, G., Troyer, D., Messing, E., Forman, J., Chin, J., Swanson, G., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.11.032 · Cited by 1,227
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
Berthold, D. R., Pond, G. R., Soban, F., de Wit, R., Eisenberger, M., & Tannock, I. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4008 · Cited by 1,145
Duration of Androgen Suppression in the Treatment of Prostate Cancer
Bolla, M., de Reijke, T. M., Van Tienhoven, G., Van den Bergh, A. C. M., Oddens, J., Poortmans, P. M. P., Gez, E., Kil, P., Akdas, A., Soete, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810095 · Cited by 970
Bolla, M., Van Tienhoven, G., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Billiet, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70223-0 · Cited by 946
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review
Chow, E., Harris, K., Fan, G., Tsao, M., & Sze, W. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.5281 · Cited by 908
Dearnaley, D. P., Sydes, M. R., Graham, J. D., Aird, E. G., Bottomley, D., Cowan, R. A., Huddart, R. A., Jose, C. C., Matthews, J. H., Millar, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70143-2 · Cited by 905
Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.-Å., Tasdemir, I., Hoyer, M., Wiklund, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61815-2 · Cited by 876
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger, M. A., Blumenstein, B. A., Crawford, E. D., Miller, G., McLeod, D. G., Loehrer, P. J., Wilding, G., Sears, K., Culkin, D. J., Thompson, I. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391504 · Cited by 859
Wiegel, T., Bottke, D., Steiner, U., Siegmann, A., Golz, R., Störkel, S., Willich, N., Semjonow, A., Souchon, R., Stöckle, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9563 · Cited by 825
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02163-2 · Cited by 819
Cuzick, J., Swanson, G. P., Fisher, G., Brothman, A. R., Berney, D. M., Reid, J. E., Mesher, D., Speights, V., Stankiewicz, E., Foster, C. S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70295-3 · Cited by 792
Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Segal, R. J., Reid, R. D., Courneya, K. S., Malone, S. C., Parliament, M. B., Scott, C. G., Venner, P. M., Quinney, H. A., Jones, L. W., Slovinec D’Angelo, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.534 · Cited by 786
Pilepich, M. V., Winter, K., John, M. J., Mesic, J. B., Sause, W., Rubin, P., Lawton, C., Machtay, M., & Grignon, D. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01579-6 · Cited by 772
D'Amico, A. V., Manola, J., Loffredo, M., Renshaw, A. A., DellaCroce, A., & Kantoff, P. W. (2004) · JAMA · doi:10.1001/jama.292.7.821 · Cited by 767
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Hanks, G. E., Pajak, T. F., Porter, A., Grignon, D., Brereton, H., Venkatesan, V., Horwitz, E. M., Lawton, C., Rosenthal, S. A., Sandler, H. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.023 · Cited by 689
Trock, B. J. (2008) · JAMA · doi:10.1001/jama.299.23.2760 · Cited by 657
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2488 · Cited by 657
Roach, M., Bae, K., Speight, J., Wolkov, H. B., Rubin, P., Lee, R. J., Lawton, C., Valicenti, R., Grignon, D., & Pilepich, M. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9881 · Cited by 649
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Bill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Warde, P., Mason, M., Ding, K., Kirkbride, P., Brundage, M., Cowan, R., Gospodarowicz, M., Sanders, K., Kostashuk, E., Swanson, G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61095-7 · Cited by 579
Porter, A. T., McEwan, A. J. B., Powe, J. E., Reid, R., McGowan, D. G., Lukka, H., Sathyanarayana, J. R., Yakemchuk, V. N., Thomas, G. M., Erlich, L. E., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90309-j · Cited by 534
Denham, J. W., Steigler, A., Lamb, D. S., Joseph, D., Turner, S., Matthews, J., Atkinson, C., North, J., Christie, D., Spry, N. A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70063-8 · Cited by 450
Serafini, A. N., Houston, S. J., Resche, I., Quick, D. P., Grund, F. M., Ell, P. J., Bertrand, A., Ahmann, F. R., Orihuela, E., Reid, R. H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1574 · Cited by 436
Tannock, I., Gospodarowicz, M., Meakin, W., Panzarella, T., Stewart, L., & Rider, W. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.590 · Cited by 407
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher, H. I., & Kelly, W. K. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1566 · Cited by 405
Denham, J. W., Steigler, A., Lamb, D. S., Joseph, D., Mameghan, H., Turner, S., Matthews, J., Franklin, I., Atkinson, C., North, J., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70348-x · Cited by 375
Andreyev, J. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70341-8 · Cited by 360
Small, E. J., Smith, M. R., Seaman, J. J., Petrone, S., & Kowalski, M. O. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.147 · Cited by 341
Quilty, P. M., Kirk, D., Bolger, J. J., Dearnaley, D. P., Lewington, V. J., Masone, M. D., Reed, N. S. E., Russell, J. M., & Yardley, J. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90411-1 · Cited by 335
Loblaw, D. A., Perry, J., Chambers, A., & Laperriere, N. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.067 · Cited by 325
Dearnaley, D., Syndikus, I., Sumo, G., Bidmead, M., Bloomfield, D., Clark, C., Gao, A., Hassan, S., Horwich, A., Huddart, R., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70293-5 · Cited by 308
Self-citationProstate cancer incidence and mortality trends in 37 European countries: An overview
Bray, F., Lortet-Tieulent, J., Ferlay, J., Forman, D., & Auvinen, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.013 · Cited by 307
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
MCLEOD, D. G., IVERSEN, P., SEE, W. A., MORRIS, T., ARMSTRONG, J., WIRTH, M. P., & the Casodex Early Prostate Cancer Trialists’ Group (2006) · BJU International · doi:10.1111/j.1464-410x.2005.06051.x · Cited by 277
An updated catalog of prostate cancer predictive tools
Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G., & Kattan, M. W. (2008) · Cancer · doi:10.1002/cncr.23908 · Cited by 264
Moul, J. W., Wu, H., Sun, L., McLeod, D. G., Amling, C., Donahue, T., Kusuda, L., Sexton, W., O’Reilly, K., Hernandez, J., et al. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.03.138 · Cited by 247
Calais da Silva, F. E. C., Bono, A. V., Whelan, P., Brausi, M., Marques Queimadelos, A., Martin, J. A. P., Kirkali, Z., Calais da Silva, F. M. V., & Robertson, C. (2009) · European Urology · doi:10.1016/j.eururo.2009.02.016 · Cited by 243
Chamberlain, M. C., Sloan, A., & Vrionis, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7029 · Cited by 231
Fosså, S. D., Slee, P. H. T., Brausi, M., Horenblas, S., Hall, R. R., Hetherington, J. W., Aaronson, N., de Prijck, L., & Collette, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.62 · Cited by 179
Bourgeois, H., Vermorken, J., Dark, G., Jones, A., Fumoleau, P., Stupp, R., Tourani, J.-M., Brain, E., Lefresne, F., & Nguyen, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.2028 · Cited by 179
Smith, D. C., Redman, B. G., Flaherty, L. E., LI, L., Strawderman, M., & Pienta, K. J. (1998) · Urology · doi:10.1016/s0090-4295(98)00173-3 · Cited by 177
Assessing Individual Risk for Prostate Cancer
Nam, R. K., Toi, A., Klotz, L. H., Trachtenberg, J., Jewett, M. A. S., Appu, S., Loblaw, D. A., Sugar, L., Narod, S. A., & Kattan, M. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6450 · Cited by 176
Parker, C. C., Heinrich, D. A., O’Sullivan, J. M., Fosså, S. D., Chodacki, A., Demkow, T., Cross, A., Bolstad, B., Garcia-Vargas, J. E., & Sartor, O. A. (2011) · European Journal of Cancer · doi:10.1016/s0959-8049(11)70100-9 · Cited by 134
Self-citationLoblaw, D. A., Perry, J. A., Chambers, A. F., & Laperrière, N. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00280-6 · Cited by 106
Johansson, E., Bill‐Axelson, A., Holmberg, L., Onelöv, E., Johansson, J., & Steineck, G. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.054 · Cited by 104
Widmark, A., Fosså, S. D., Lundmo, P. I., Damber, J. ‐., Vaage, S., Damber, L., Wiklund, F. E., & Klepp, O. (2003) · Urology · doi:10.1016/s0090-4295(02)02107-6 · Cited by 101
Efficacy of low‐dose dexamethasone in castration‐refractory prostate cancer
Venkitaraman, R., Thomas, K., Huddart, R. A., Horwich, A., Dearnaley, D. P., & Parker, C. C. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07261.x · Cited by 79
Self-citationKinney, A. Y., Vernon, S. W., Frankowski, R. F., Weber, D. M., Bitsura, J. M., & Vogel, V. G. (1995) · Cancer · doi:10.1002/1097-0142(19950701)76:1<96::aid-cncr2820760114>3.0.co;2-e · Cited by 68
Denham, J. W. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70152-3 · Cited by 6
Cited by
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
Fizazi, K., Piulats, J. M., Reaume, M. N., Ostler, P., McDermott, R., Gingerich, J. R., Pintus, E., Sridhar, S. S., Bambury, R. M., Emmenegger, U., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2214676 · Cited by 449
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Calais, J., Ceci, F., Cho, S. Y., Fanti, S., Giesel, F. L., Goffin, K., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06089-w · Cited by 410
Montorsi, F., Wilson, T. G., Rosen, R. C., Ahlering, T. E., Artibani, W., Carroll, P. R., Costello, A., Eastham, J. A., Ficarra, V., Guazzoni, G., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.057 · Cited by 315
Saad, F., Carles, J., Gillessen, S., Heidenreich, A., Heinrich, D., Gratt, J., Lévy, J., Miller, K., Nilsson, S., Petrenciuc, O., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30173-5 · Cited by 294
Metadata
- Authors
- Horwich, A., Parker, C., Bangma, C., & Kataja, V.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 21
- Issue
- 9
- Pages
- v129-v133
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2148987788
- Cited by
- 600
- References
- 62
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.